Aaron Gitler
About Aaron Gitler
Aaron Gitler is a VP of Science and a professor in the Department of Genetics at Stanford University, known for his significant contributions to ALS research, including the discovery of genetic contributors and therapeutic targets.
Aaron Gitler's Professional Title
Aaron Gitler serves as the Vice President of Science and is a Professor in the Department of Genetics at Stanford University. He holds the position within Stanford Medicine Basic Science.
Aaron Gitler's Education and Training
Aaron Gitler received his Bachelor of Science degree from Penn State University. He completed his PhD studies under Dr. Jonathan Epstein at the University of Pennsylvania, where he focused on cardiovascular development. Postdoctoral training was undertaken with Dr. Susan Lindquist at the Whitehead Institute for Biomedical Research and MIT.
Aaron Gitler's Academic Background
Aaron Gitler founded his laboratory at the University of Pennsylvania in 2007 before moving to Stanford University in 2012. His research uses yeast and human genetics to explore the pathogenic mechanisms behind Amyotrophic Lateral Sclerosis (ALS).
Aaron Gitler's Research Discoveries
Aaron Gitler's laboratory has made significant contributions to ALS research. He discovered that mutations in the ATAXIN2 gene are a genetic contributor to ALS. His team has also identified several therapeutic targets for the disease.
Aaron Gitler's Role in Maze Therapeutics
Aaron Gitler is a scientific co-founder of Maze Therapeutics, a company focused on translating genetic insights into new medicines.